NCT03687853

Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: Peking University Third Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Clinical results on intra-arterial adjuvant chemotherapy for prevention of liver metastasis following curative resection of pancreatic cancer

Detailed description

In this study, the investigator try to select 80 patients who received radical surgery for pancreatic cancer, whose circulating tumor cells(CTCs) count then performed on intraoperative portal venous blood to predict postoperative liver metastasis and were divided into two groups. for those who have high CTCs count may have more chance for the occurrence of postoperative liver metastasis was applied hepatic arterial perfusion chemotherapy with minimal dynamic randomization. The aim is to evaluate the feasibility of hepatic arterial infusion chemotherapy for the prevention of postoperative liver metastasis and improvement of prognosis of pancreatic cancer, so as to further improve postoperative management of pancreatic cancer

Conditions

• Pancreatic Ductal Adenocarcinoma
• Who Have High CTCs Count in Portal Venous Blood
• Liver Metastases

Interventions

Type	Name	Description
DEVICE	Intrahepatic Arterial Infusion	Intrahepatic Arterial Infusion chemotherapy is one of the most widely used liver tumor treatments.

Timeline

• Start date: 2017-01-01
• Primary completion: 2018-12-31
• Completion: 2019-12-31
• First posted: 2018-09-27
• Last updated: 2018-09-27

Locations

1 site across 1 country: China